GW&K Investment Management’s Dynavax Technologies DVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-241,882
Closed -$3.72M 1020
2025
Q4
$3.72M Sell
241,882
-11,548
-5% -$127K 0.03% 282
2025
Q3
$2.52M Buy
253,430
+52,380
+26% +$545K 0.02% 296
2025
Q2
$1.99M Sell
201,050
-8,180
-4% -$86.2K 0.02% 306
2025
Q1
$2.71M Sell
209,230
-5,525
-3% -$73.1K 0.03% 295
2024
Q4
$2.74M Sell
214,755
-20,790
-9% -$251K 0.02% 302
2024
Q3
$2.62M Buy
+235,545
New +$2.6M 0.02% 298
2016
Q3
Sell
-160,213
Closed -$2.34M 221
2016
Q2
$2.34M Buy
160,213
+18,794
+13% +$321K 0.05% 206
2016
Q1
$2.72M Buy
141,419
+66,964
+90% +$1.35M 0.06% 194
2015
Q4
$1.8M Buy
74,455
+13,450
+22% +$337K 0.04% 193
2015
Q3
$1.5M Buy
61,005
+1,635
+3% +$46.3K 0.04% 191
2015
Q2
$1.39M Sell
59,370
-70
-0.1% -$1.52K 0.03% 201
2015
Q1
$1.33M Buy
+59,440
New +$1.14M 0.03% 202

Other funds holding DVAX

GW&K Investment Management's DVAX Position: Q1 2026 in Review

GW&K Investment Management sold out of Dynavax Technologies (DVAX) in Q1 2026, closing a stake of 241,882 shares — an estimated $3.72M sold.

GW&K Investment Management first reported a position in DVAX in Q1 2015 and held it in 12 quarters. The position peaked at $3.72M in Q4 2025. 1 fund tracked by Wall St. Rank holds DVAX as of Q1 2026.

  • GW&K Investment Management reported no remaining Dynavax Technologies position as of Q1 2026 after selling out during the quarter.
  • GW&K Investment Management sold 241,882 Dynavax Technologies shares in Q1 2026, an estimated $3.72M.
  • GW&K Investment Management first reported a position in Dynavax Technologies in Q1 2015 and held it in 12 quarters.
  • GW&K Investment Management's Dynavax Technologies position peaked at $3.72M in Q4 2025.
  • 1 fund tracked by Wall St. Rank held Dynavax Technologies as of Q1 2026.

Based on GW&K Investment Management's 13F filing for Q1 2026, filed 13 May 2026.